Abstract

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021

Uyoga S, Adetifa IMO, Otiende M, Yegon C, Agweyu A, Warimwe GM, Scott JAG
JAMA. 2021;326

Permenent descriptor
https://doi.org/10.1001/jama.2021.15265


This study examines the prevalence of SARS-CoV-2 antibodies among blood donors aged 16 to 64 years in Kenya from January to March 2021.

Publication metrics
Dimensions Badge

Altmetric

Key Terms
Adolescent | Adult | Antibodies, Viral/*blood | *Blood Donors | COVID-19/diagnosis/*epidemiology | COVID-19 Serological Testing | Female | Humans | Kenya | Male (Source: Medline)
Funded by
Bill and Melinda Gates Foundation [INV-017547]; Wellcome Trust [220991/Z/20/Z, 203077/Z/16/Z]; Foreign Commonwealth and Development Office
External Sources
Abstract at pubmed
Full text at publishers website
Full text at PMC